367 related articles for article (PubMed ID: 11156420)
1. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
2. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer.
Kholodnyuk ID; Kost-Alimova M; Yang Y; Kiss H; Fedorova L; Klein G; Imreh S
Genes Chromosomes Cancer; 2002 Jul; 34(3):341-4. PubMed ID: 12007195
[TBL] [Abstract][Full Text] [Related]
3. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice.
Kholodnyuk I; Kost-Alimova M; Kashuba V; Gizatulin R; Szeles A; Stanbridge EJ; Zabarovsky ER; Klein G; Imreh S
Genes Chromosomes Cancer; 1997 Mar; 18(3):200-11. PubMed ID: 9071573
[TBL] [Abstract][Full Text] [Related]
4. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth.
Imreh S; Kost-Alimova M; Kholodnyuk I; Yang Y; Szeles A; Kiss H; Liu Y; Foster K; Zabarovsky E; Stanbridge E; Klein G
Genes Chromosomes Cancer; 1997 Nov; 20(3):224-33. PubMed ID: 9365829
[TBL] [Abstract][Full Text] [Related]
5. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM.
Szeles A; Yang Y; Sandlund AM; Kholodnyuk I; Kiss H; Kost-Alimova M; Zabarovsky ER; Stanbridge E; Klein G; Imreh S
Genes Chromosomes Cancer; 1997 Dec; 20(4):329-36. PubMed ID: 9408748
[TBL] [Abstract][Full Text] [Related]
6. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors.
Yang Y; Kiss H; Kost-Alimova M; Kedra D; Fransson I; Seroussi E; Li J; Szeles A; Kholodnyuk I; Imreh MP; Fodor K; Hadlaczky G; Klein G; Dumanski JP; Imreh S
Genomics; 1999 Dec; 62(2):147-55. PubMed ID: 10610706
[TBL] [Abstract][Full Text] [Related]
7. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
8. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice.
Kholodnyuk ID; Kozireva S; Kost-Alimova M; Kashuba V; Klein G; Imreh S
Int J Cancer; 2006 Jul; 119(1):99-107. PubMed ID: 16432833
[TBL] [Abstract][Full Text] [Related]
9. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
[TBL] [Abstract][Full Text] [Related]
10. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the FHIT gene in human hepatocellular carcinoma.
Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
[TBL] [Abstract][Full Text] [Related]
12. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
[TBL] [Abstract][Full Text] [Related]
13. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
14. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
[TBL] [Abstract][Full Text] [Related]
15. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
16. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
18. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
19. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
20. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
